Suggestions

Suggestions

Biotechnology

From Oil to Biofactories: The Silent Rise of a $150 Billion Green Manufacturing Superpower
········

The $150 Billion Biofactory Boom: How Industrial Biotech Is Poised to Take On Oil

What is industrial biotechnology—and why does it matter now? Industrial biotechnology (often called “white biotechnology”) uses living systems—microbes, enzymes, and cells—to make materials, chemicals, fuels, food ingredients, and other industrial products, often replacing fossil‑based or harsh chemical processes. Instead of cracking oil
November 27, 2025
Breakthrough Brain Implant Can Target Multiple Brain Regions at Once
··········

Breakthrough Brain Implant Can Target Multiple Brain Regions at Once – Could It Transform Treatment for Epilepsy, Parkinson’s, and Brain Cancer?

A new multi‑region drug‑delivery implant Scientists at New York University in Abu Dhabi have engineered a helical micro‑catheter that can infuse medication from multiple, precisely placed outlets, enabling clinicians to reach several brain regions at once from a single, minimally invasive path.
October 26, 2025
CRISPR
············

CRISPR Exposed: How Bacteria’s Immune System Became the Gene-Editing Revolution

Scientific background and discovery of CRISPR CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) was first observed as odd repeating DNA sequences in bacteria by Ishino et al. in 1987 pmc.ncbi.nlm.nih.gov, but its function remained mysterious for years. In the 1990s, microbiologists like
September 25, 2025
AlphaFold 3
··················

AlphaFold 3 Unleashed: Revolutionary AI Decodes DNA, RNA and Proteins to Supercharge Drug Discovery

What is AlphaFold 3 and How It Differs from AlphaFold 2 AlphaFold 3 is the latest generation of DeepMind’s AI for molecular structure prediction. Like AlphaFold 2, it takes genetic or molecular sequences as input and predicts 3D shapes. The key difference
September 21, 2025
Cancer Vaccines
·······················

The Race for Personalized mRNA Cancer Vaccines: Phase 3 Trials Aim to Transform Melanoma and Lung Cancer Treatment

Key Facts Global Phase 3 Trials: Melanoma Leads the Way The first personalized mRNA cancer vaccine to reach Phase 3 is Moderna’s mRNA-4157 (V940) in melanoma – a groundbreaking collaboration with Merck that has quickly become a bellwether for the field. Melanoma
September 13, 2025